RxDoctor Payments Data

Billy Noel

General Practice · Fort Smith, ARNPI 1790716314

Payments from drug & device makers

$1,257in general payments, 2019–2025

Across 67 payments — averaging $18.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$739
  • Paratek Pharmaceuticals, Inc.$255
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$185
  • Medtronic$36
  • Axsome Therapeutics, Inc.$18
  • Kowa Pharmaceuticals America, Inc.$13
  • plus $11 from 1 others

What the payments were for

  • Food & beverage$1,257100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,257 in reported general payments places this provider in the 85th percentile of 720 general practice providers in Arkansas.

See all general practice providers in Arkansas

Medicare billing

Part B allowed, 2024
$36,178
Medicare patients
86
Services billed
421

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide46$42,285
Abilify MaintenaAripiprazole12$38,802
Invega SustennaPaliperidone Palmitate11$38,495
EliquisApixaban51$30,855
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen878$29,212
TrulicityDulaglutide26$22,586
VraylarCariprazine Hcl13$17,974
Combivent RespimatIpratropium/Albuterol Sulfate19$9,274
Albuterol Sulfate HfaAlbuterol Sulfate137$3,161
Gabapentin296$3,001
Omeprazole214$2,601
Pregabalin140$2,417
Celecoxib187$1,992
Tizanidine Hcl141$1,575
Ibuprofen117$1,499

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$11$30,85551 claims
AbbVieVraylar, Synthroid$739$18,52525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 720 general practice providers in Arkansas.

Other general practice in Fort Smith

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →